1. Robinson L.B., Landman A.B., Shenoy E.S., et al.: Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination. J Allergy Clin Immunol Pract. 2021 Aug; 9 (8): 3200–3202.
2. Krantz M.S., Bruusgaard-Mouritsen M.A., Koo G., Phillips E.J., Stone C.A., Garvey L.H.: Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: Don’t give up on the second dose! Allergy. 2021 Sep; 76 (9): 2916–2920. doi:
10.1111/all.14958 3. CDC COVID-19 Response Team, FDA: Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020. Centers for Disease Control and Prevention. 2021.
https://www.cdc.gov/mmwr/volumes/70/wr/mm7002e1.htm (Accessed 02 Apr 2021).
4. CDC COVID-19 Response Team, Administration FDA: Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine — United States, December 21, 2020–January 10, 2021. MMWR Morb Mortal Wkly Rep. 2021; 70: 125e9.
5. Narodowy Instytut Zdrowia: Niepożądane Odczyny Poszczepienne po szczepionkach przeciw COVID-19 w Polsce. Raport za okres 27.12.2020–31.07.2021.
https://www.pzh.gov.pl/wp-content/uploads/2021/08/Raport-NOP-do-31.07.2021.pdf (Accessed 10 Aug 2021).
6. Cabanillas B., Novak N.: Allergy to COVID-19 vaccines: A current update. Allergol Int. 2021 Jul; 70 (3): 313–318. doi:
10.1016/j.alit.2021.04.003 7. Kruszewski J., Cichocka-Jarosz E., Czarnobilska E., et al.: Recommendations of the Polish Society of Allergology on the qualification of person with allergies and anaphylaxis to vaccination against COVID-19. Alergologia Polska — Polish Journal of Allergology. 2021; 8, 1: 1–8. doi:
https://doi.org/10.5114/pja.2021.10422 8. Hyun-Jun J., Chan Young S., Kyu-Bong K.: Safety Evaluation of Polyethylene Glycol (PEG) Compounds for Cosmetic Use. Toxicol Res. 2015 Jun; 31(2):105–136. doi:
10.5487/TR.2015.31.2.105 9. Wenande E., Garvey L.H.: Immediate-type hypersensitivity to polyethylene glycols: a review. Clin Exp Allergy 2016 Jul; 46 (7): 907–922. doi:
10.1111/cea.12760 10. Stone C.A. Jr., Liu Y., Relling M.V., et al.: Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized. J Allergy Clin Immunol Pract. 2019 May– Jun; 7 (5): 1533–1540.e8. doi:
10.1016/j.jaip.2018.12.003 11. Castells M.C., Phillips E.J.: Maintaining Safety with SARS-CoV-2 Vaccines. N Engl J Med. 2021 Feb; 384 (7): 643–649. doi:
10.1056/NEJMra2035343 12. Klimek L., Jutel M., Akdis C.A., et al.: ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines — An EAACI-ARIA Position Paper. Allergy. 2021 Jun; 76 (6): 1624–1628. doi:
10.1111/all.14726 13. Klimek L., Bergmann K.C., Brehler R., et al.: Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI. Allergo J Int. 2021 Apr; 1–17. doi:
10.1007/s40629-021-00165-7 14. Rutkowski K., Mirakian R., Till S., Rutkowski R., Wagner A.: Adverse reactions to COVID-19 vaccines: A practical approach. Clin Exp Allergy. 2021 Jun; 51 (6): 770–777. doi:
10.1111/cea.13880 15. Pawliczak R.: Alergologia-kompendium. In: Pawliczak R., ed. Mechanizmy uczulenia. 1st Ed. Poznań: Termedia Wydawnictwa Medyczne; 2013; 31–35.
16. Giavina-Bianchi P., Kalil J.: Polyethylene Glycol Is a Cause of IgE-Mediated Anaphylaxis. J Allergy Clin Immunol Pract. 2019; 7 (6): 1874–1875. doi:
10.1016/j.jaip.2019.05.001 17. Wenande E.C., Skov P.S., Mosbech H., Poulsen L.K., Garvey L.H.: Inhibition of polyethylene glycol- induced histamine release by monomeric ethylene and diethylene glycol: a case of probable polyethylene glycol allergy. J Allergy Clin Immunol. 2013 May; 131 (5): 1425–1427. doi:
10.1016/j.jaci.2012.09.037 18. Borderé A., Stockman A., Boone B., et al.: A case of anaphylaxis caused by macrogol 3350 after injection of a corticosteroid. Contact Dermatitis. 2012 Dec; 67 (6): 376–378. doi:
10.1111/j.1600-0536.2012.02104.x 19. Wylon K., Dölle S., Worm M.: Polyethylene glycol as a cause of anaphylaxis. Allergy Asthma Clin Immunol. 2016 Dec; 12: 67. doi:
10.1186/s13223-016-0172-7. eCollection 2016.
20. Cox F., Khalib K., Conlon N.: PEG That Reaction: A Case Series of Allergy to Polyethylene Glycol. J Clin Pharmacol. 2021 Jun; 61 (6): 832–835. doi:
10.1002/jcph.1824. Epub 2021 Feb 28.
21. Greenhawt M., Abrams E.M., Oppenheimer J.: The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World. J Allergy Clin Immunol Pract. 2021 Apr; 9 (4): 1438–1441. doi:
10.1016/j.jaip.2021.01.022 22. Bruusgaard-Mouritsen M.A., Jensen B.M., Poulsen L.K., Duus Johansen J., Garvey L.H.: Optimizing investigation of suspected allergy to polyethylene glycols. J Allergy Clin Immunol. 2021 May; S0091-6749(21)00825-3. doi:
10.1016/j.jaci.2021.05.020 23. Pickert J., Hennighausen I., Mühlenbein S., Möbs C., Pfützner W.: Immediate-Type Hypersensitivity to Polyethylene Glycol (PEG) Including a PEG-containing COVID-19 Vaccine Revealed by Intradermal Testing. J Investig Allergol Clin Immunol. 2021 Jun; 15: 0. doi:
10.18176/jiaci.0720 24. Wolfson A.R., Robinson L.B., Li L., et al.: First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing. J Allergy Clin Immunol Pract. 2021 Sep; 9 (9): 3308–3320.e3. doi:
10.1016/j.jaip.2021.06.010 25. Santos A.F., Alpan O., Hoffmann H.J.: Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice. Allergy. 2021 Aug; 76 (8): 2420–2432. doi:
10.1111/all.14747 26. Ansotegui I.J., Melioli G., Canonica G.W., et al.: IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper. World Allergy Organ J. 2020 Feb; 13 (2): 100080. doi:
10.1016/j.waojou.2019.100080 27. Spiewak R.: Eczema and food allergy — is there a causal relationship? Przegl Lek. 2013; 70 (12): 1051– 1055.
28. Braun W.: Contact allergies to polyethylene glycols. Z Haut Geschlechtskr. 1969 Jun; 44 (11): 385– 389.
29. Bajaj A.K., Gupta S.C, Chatterjee A.K., Singh K.G.: Contact sensitivity to polyethylene glycols. Contact Dermatitis. 1990 May; 22 (5): 291–292. doi:
10.1111j.16000536.1990.tb01602.x 30. Özkaya E, Kılıç S.: Polyethylene glycol as marker for nitrofurazone allergy: 20 years of experience from Turkey. Contact Dermatitis. 2018 Mar; 78 (3): 211–215. doi:
10.1111/cod.12931 31. Caballero M.L., Quirce S.: Delayed Hypersensitivity Reactions Caused by Drug Excipients: A Literature Review. J Investig Allergol Clin Immunol. 2020; 30 (6): 400–408. doi:
10.18176/jiaci.0562 32. Bruusgaard-Mouritsen M.A., Johansen J.D., Garvey L.H.: Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients. Clin Exp Allergy. 2021 Mar; 51 (3): 463– 470. doi:
10.1111/cea.13822
en
pl
